Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 361-368

  Jadus, Martin R ^a,b   Williams, Christopher C ^a,b   Avina, Maria D ^a,b   Ly, Mann ^a,b   Kim, Suzanna ^a,b   Liu, Ying ^a,b   Narasaki, Ryan ^a,b   Lowell, Clifford A ^c   Wepsic, H Terry ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; COLCHICINE; COLONY STIMULATING FACTOR 1; CYTOCHALASIN B; DEOXYGLUCOSE; GADOLINIUM CHLORIDE; IODOACETIC ACID; LIPOCORTIN 5; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL KILLING; CONTROLLED STUDY; GLIOMA CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MARROW CELLS; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; GLIOMA; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MEMBRANE PROTEINS; NG-NITROARGININE METHYL ESTER; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031929658     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fidler, I. J. 1985. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res. 45:4714 (Presidential Address).
2. Fidler, I. J., Z. Barnes, W. E. Fogler, R. Kirsch, P. Bugelski, and G. Poste. 1982. Involvement of macrophages in eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 42:496.
3. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265.
4. Klein, E., and A. Mantovani. 1993. Action of natural killer and macrophages in cancer. Curr. Opin. Immunol. 5:714.
5. Russell, S. W., W. F. Doe, and A. T. McIntosh. 1977. Functional characterization of a stable nonlytic stage of macrophage activation in tumors. J. Exp. Med. 146: 1511.
6. Adams, D. O., and A. P. Marino. 1981. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. J. Immunol. 126:981.
7. Pace, J. L., S. W. Russell, B. A. Torres, H. M. Johnson, and P. W. Gray. 1983. Recombinant mouse interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130:2011.
8. Young, D. A., L. D. Lowe, and S. C. Clark. 1990. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. J. Immunol. 145:607.
9. Hori, K., M. J. Ehrke, K. Mace, D. Maccubbin, M. J. Doyle, Y. Otsuka, and E. Mihich. 1987. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity. Cancer Res. 47:2793.
10. Mufson, R. A., J. Aghajanian, G. Wong, C. Woodhouse, and A. C. Morgan. 1989. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody dependent cell-mediated cytotoxicity. Cell, Immunol. 119:182.
11. Wing, E. J., N. M. Ampel, A. Waheed, and R. K. Shadduck. 1985. Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J. Immunol. 135:2052.
12. Suzu, S., H. Yokota, M. Yamada, N. Yanai, M. Saito, T. Kawashima, M. Saito, F. Takaku, and K. Motoyoshi. 1989. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res. 49:5013.
13. Manthey, C. L., P. Y. Perera, C. A. Salkowski, and S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152:825.
14. Feinman, R., D. Henriksen-De Stephano, M. Tsujimoto, and J. Vilcek. 1987. Tumor necrosis factor is an important mediator of tumour cell killing by human monocytes. J. Immunol. 138:635.
15. Green, S. J., T. Y. Chen, R. M. Crawford, C. A. Nacy, D. C. Morrison, and M. S. Meltzer. 1992. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-γ and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. J. Immunol. 149:2069.
16. Martin, J. H. J., and S. W. Edwards. 1993. Changes in mechanisms of monocyte/ macrophage-mediated cytotoxicity during culture. J. Immunol. 150:3478.
17. Drapier, J. C., and J. B. Hibbs. 1988. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140:2829.
18. Zarling, J. M., M. Shoyab, H. Marquardt, M. B. Hanson, M. N. Lioubin, and G. J. Todaro. 1986. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83:9739.
19. Cerreti, D. P., J. Wignall, and D. Anderson. 1988. Human macrophage colony-stimulating factor: alternative RNA and protein processing from a single gene. Mol. Immunol. 25:277.
20. Stanley, E. R. 1991. Colony-stimulating factor-1. In Human Cytokines. B. B. Aggarwal, G. U. Gutterman, eds. Blackwell Scientific, Boston, p. 196.
21. Stein, J., G. V. Borzillo, C. W. Rettenmier. 1990. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by plasma membrane-bound precursor of human CSF-1. Blood 76:1308.
22. Ramakrishnan, S., F. J. Xu, J. Brandt, J. E. Niedel, R. C. Bast, and E. L. Brown. 1989. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J. Clin. Invest. 83:921.
23. Kacinski, B. M. 1995. CSF-1 and its receptor in ovarian, endometrial, and breast cancer. Ann. Med. 27:79.
24. Chambers, S. K., Y. Wang, R. E. Gertz, and B. M. Kacinski. 1995. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res. 55:1578.
25. Scholl, S. M., C. Pallud, F. Beuvon, K. Hacene, E. R. Stanley, L. Rohrschneider, R. Tang, P. Pouillart, and R. Lidereau. 1994. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlated with marked inflammatory cell infiltrates and prognosis. J. Natl. Cancer Instit. 86:120.
26. Kacinski, B. M., K. A. Scata, D. Carter, L. D. Yee, E. Sapi, B. L. King, S. K. Chambers, M. A. Jones, M. H. Pirro, E. R. Stanley, and L. R. Rohrschneider. 1991. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinoma in vivo and in vitro. Oncogene 6:941.
27. Jadus, M. R., M. C. N. Irwin, M. R. Irwin, R. N. Horansky, S. Sektion, K. Pepper, D. B. Kohn, and H. T. Wepsic. 1996. Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor. Blood 87:5232.
28. Jadus, M. R., M. R. Irwin, B. E. Barton, M. N. Irwin, and H. T. Wepsic. 1995. The identification of the neonatal NBXFO hybridoma cell and its mediator. Devel. Compar. Immunol. 19:261.
29. Jadus M. R., S. Sekhon, B. E. Barton, and H. T. Wepsic. 1995. Macrophage colony-stimulating factor-activated bone marrow macrophages suppress lymphocytic responses through phagocytosis: a tentative in vitro model of Rosai-Dorfman Disease. J. Leuko. Biol. 57:936.
30. 2 release from human granulocytes during phagocytosis. J. Clin. Invest. 55:945.
31. Quintrell N., R. Lebo, H. Varmus, M. Bishop, M. J. Pettenati, M. M. LeBeau, M. O. Diaz and J. D. Rowley. 1987. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hematopoietic cells. Mol. Cell. Biol. 7:2267.
32. Smith, D. L., and F. Rommel. 1977. A rapid micro method for the simultaneous determination of phagocytic-microbicidal activity of human peripheral blood leukocytes in vitro. J. Immunol. Methods 17:241.
33. Ly, M., M. C. N. Irwin, M. R. Irwin, H. T. Wepsic, and M. R. Jadus. 1996. Modification of a commercially available ELISA kit to quantitate the membrane isoform of macrophage colony-stimulating factor on cells. Biotechniques 21:980.
34. Bottazzi, B., E. Erba, N. Nobili, F. Fazioli, A. Rambaldi, and A. Mantovani. 1990. A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J. Immunol. 144:2409.
35. Erroi, A, M. Sironi, F. Chiaffarino, C. Zhen-Guo, M. Mengozzi, and A. Mantovani. 1989. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer 44:795.
36. Brocker, E. B., G. Zwadlo, L. Suter, M. Brune, C. Sorg. 1987. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. Cancer Immunol. Immunother. 25:81.
37. Mussoni, L., M. Riganti, R. Acero, A. Erroi, G. Conforti, A. Mantovani, and M. B. Donati. 1988. Macrophages associated with murine tumours express plasminogen activator activity. Int. J. Cancer 41:227.
38. Nikcevich, D. A., M. R. Young, N. K. Ellis, M. Newby, and H. T. Wepsic HT. 1986. Stimulation of hematopoiesis in untreated and cyclophosphamide-treated mice by the inhibition of prostaglandin synthesis. J. Immunopharmacol. 8:299.
39. Nikcevich, D. A., G. P. Duffie, M. R. Young, N. K. Ellis, G. E. Kaufman, and H. T. Wepsic. 1986. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57BL/6 mice. Cell. Immunol. 109:349.
40. Allen C., and N. Hogg. 1987. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8 positive T cells and mononuclear phagocytes. Cancer Res. 47:2919.
41. + mononuclear cells in the tumor stroma. Int. J. Cancer 35:199.
42. Brocker, E. B., G. Zwadlo, B. Holzmann, E. Macher, and C. Sorg. 1988. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int. J. Cancer 41:562.
43. Hibbs, J. B., L. H. Lambert, and J. S. Remington. 1972. Possible role of macrophage-mediated nonspecific cytotoxicity in tumor resistance. Nature 235:48.
44. Fidler, I. J., Z. Barnes, W. E. Fogler, R. Kirsch, P. Bugelski, and G. Poste. 1982. Involvement of macrophages in eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 42:496.
45. Hume, D. A., R. E. Donahue, and I. J. Fidler. 1989. The therapeutic effect of human recombinant macrophage colony-stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res. 8:69.
46. Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251.
47. Dorsch, M., H. Hock, U. Kunzendorf, T. Diamantstein, and T. Blackenstein. 1993. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur. J. Immunol. 23: 186.
48. Walsh, P., A. Dorner, R. C. Duke, L. J. Su, and L. M. Glode. 1995. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma. J. Natl. Cancer Instil. 87:809.
49. Monta, T., K. Ikeda, M. Douzono, M. Yamada, F. Kimura, K. Kawakami, K. Sasaki, K. Motoyoshi, J. Takahara, and S. Irino. 1996. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 88:955.
50. Kimura, F., M. Douzono, J. Ohta, T. Morita, K. Ikeda, Y. Nakamura, K. Sato, M. Yamada, N. Nagata, and K. Motoyoshi. 1996. Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells. Exp. Hematol. 24: 360.